A multidisciplinary team at the University of Pennsylvania has used machine learning to develop a liquid biopsy that can detect early stages of the most common form of pancreatic cancer by measuring multiple biomarkers in a single blood sample.
In a blinded study, the multi-analyte test was found to be more accurate than single biomarker analysis at detecting pancreatic ductal adenocarcinoma (PDAC), and was also better at staging disease than stand-alone imaging. Read more . . .